Ellrott et al. provide a means to assign patient samples from clinical trials and other cancer genome studies to published TCGA molecular subtypes. Applying machine learning to data from five different molecular platforms for 8,791 TCGA tumor samples, they contribute a public resource of 737 top classifier models, which can form the foundation for clinical assay development.
My entire life I was told to respectfully question anything and everything, because questions equal answers, which provide understanding and thereby comfort—even with the uncomfortable.…
In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.
Serial CTRS, an AI-powered tool, has been granted FDA breakthrough device designation for classifying patients with NSCLC.
Find 5 helpful tips about using keywords in your research article to help journals, and your article, be found more easily by researchers.
Join us for an ARC Talks webinar to explore the basics of amyloidosis. Dr. Sarah Cuddy, cardiologist at Brigham and Women’s Hospital, will present an…
10 February 2025 The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday, February 10) published advice…
A team of colleagues at Fox Chase Cancer Center recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for…
In this video, Pere Barba, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, shares updated results from the FELIX trial (NCT04404660), which is evaluating the…
An abstract is unavailable.
Key PointsCNS relapse rate in HGBCL-DH-BCL2 (6.8% at 2 years) is much lower than previously reported and is associated with clinical risk factors.DZsig ref
